D. Bourchier et Pj. Weston, RANDOMIZED TRIAL OF DOPAMINE COMPARED WITH HYDROCORTISONE FOR THE TREATMENT OF HYPOTENSIVE VERY-LOW-BIRTH-WEIGHT INFANTS, Archives of Disease in Childhood, 76(3), 1997, pp. 174-178
Aim-To compare the efficacy of hydrocortisone with dopamine for the tr
eatment of hypotensive, very low birthweight (VLBW) infants. Methods-F
orty infants were randomly allocated to receive either hydrocortisone
(n=21) or dopamine (n=19). Results-All 19 infants randomised to dopami
ne responded; 17 of 21 (81%) did so in the hydrocortisone group. Three
of the four non-responders in the hydrocortisone group had clinically
significant left to right ductal shunting. The incidence of bronchopu
lmonary dysplasia, retinopathy of prematurity, intraventricular haemor
rhage, necrotising enterocolitis, symptomatic patent ductus arteriosus
, hyperglycaemia, sepsis (bacterial or fungal) or survival did not dif
fer between groups. The adrenocorticotrophic hormone (ACTH) stimulated
plasma cortisol activity, either before or after treatment, did not d
iffer between the two groups of infants. Although a significant differ
ence in efficacy between dopamine and hydrocortisone was not noted (P
= 0.108), there were four treatment failures in the hydrocortisone gro
up, compared with none in the dopamine group.Conclusion-Both hydrocort
isone and dopamine are effective treatments for hypotension in very lo
w birthweight infants.